Keung YK - Search Results

1

The transplant iron score as a predictor of stem cell transplant survival.

Storey JA, Connor RF, Lewis ZT, Hurd D, Pomper G, Keung YK, Grover M, Lovato J, Torti SV, Torti FM, Molnár I. Storey JA, et al. Among authors: keung yk. J Hematol Oncol. 2009 Oct 24;2:44. doi: 10.1186/1756-8722-2-44. J Hematol Oncol. 2009. PMID: 19852846 Free PMC article.

2

Treatment of post-transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograft.

Molnar I, Keung YK. Molnar I, et al. Among authors: keung yk. Nephrol Dial Transplant. 2001 Oct;16(10):2114-5. doi: 10.1093/ndt/16.10.2114. Nephrol Dial Transplant. 2001. PMID: 11572917 No abstract available.

3

Porphyria cutanea tarda in a patient with post-transplant MDS.

Oubre D, Cruz J, Keung Y. Oubre D, et al. Bone Marrow Transplant. 2001 Jan;27(2):219-20. doi: 10.1038/sj.bmt.1702747. Bone Marrow Transplant. 2001. PMID: 11281395

4

When medical meets spiritual.

Keung YK, McQuellon R. Keung YK, et al. N C Med J. 2001 Jul-Aug;62(4):192-4; discussion 195. N C Med J. 2001. PMID: 11468981 Review. No abstract available.

5

Acute myeloid leukemia with complex cytogenetic abnormalities associated with long-term use of oral colloidal silver as nutritional supplement - Case report and review of literature.

Keung YK, Wang T, Hong-Lung Hu E. Keung YK, et al. J Oncol Pharm Pract. 2020 Jan;26(1):212-215. doi: 10.1177/1078155219832966. Epub 2019 Mar 9. J Oncol Pharm Pract. 2020. PMID: 30854923 Review.

6

Spontaneous hematoma of the thigh associated with antiproteinase-3 antibody in a patient with metastatic squamous cell carcinoma treated with nivolumab.

Keung YK, Hu EH. Keung YK, et al. J Oncol Pharm Pract. 2019 Jul;25(5):1261-1264. doi: 10.1177/1078155218786352. Epub 2018 Jul 9. J Oncol Pharm Pract. 2019. PMID: 29984627

7

Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature.

Zurayk M, Keung YK, Yu D, Hu EH. Zurayk M, et al. Among authors: keung yk. J Oncol Pharm Pract. 2019 Jan;25(1):234-238. doi: 10.1177/1078155217732141. Epub 2017 Sep 26. J Oncol Pharm Pract. 2019. PMID: 28950804 Review.

8

A case of recurrent pancytopenia in a patient with acute promyelocytic leukemia on maintenance chemotherapy and concomitant methyltetrahydrofolate reductase and thiopurine S-methyltransferase mutation - review of literature.

Keung YK, Keung LW, Hong-Lung Hu E. Keung YK, et al. J Oncol Pharm Pract. 2016 Jun;22(3):548-51. doi: 10.1177/1078155215577235. Epub 2015 Mar 18. J Oncol Pharm Pract. 2016. PMID: 25791511 Review.

9

Possible role of engraftment syndrome and autologous graft-versus-host disease in myelodysplastic syndrome after autologous stem cell transplantations: retrospective analysis and review of the literature.

Keung YK, Beaty MW, Pettenati M, Levitan D, Hurd DD. Keung YK, et al. Clin Lymphoma Myeloma Leuk. 2010 Apr;10(2):129-33. doi: 10.3816/CLML.2010.n.018. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20371446 Review.

10

Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?

Keung YK, Levitan D, Zamkoff K, Hurd D. Keung YK, et al. Bone Marrow Transplant. 2010 Feb;45(2):407-8. doi: 10.1038/bmt.2009.156. Epub 2009 Jul 27. Bone Marrow Transplant. 2010. PMID: 19633689 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page